Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 32

1.

Hypercoagulable Workup in Thrombotic Cardiovascular Diseases.

Shen YM, Nagalla S.

Circulation. 2018 Jul 17;138(3):229-231. doi: 10.1161/CIRCULATIONAHA.117.031699. No abstract available.

PMID:
30012700
2.

The Novel Protease-Activated Receptor 1 Antagonist Vorapaxar as a Treatment for Thrombosis in Afibrinogenemia.

Tawfik B, Pollard E, Shen YM.

Semin Thromb Hemost. 2018 Jun;44(4):404-406. doi: 10.1055/s-0038-1654715. Epub 2018 May 15. No abstract available.

PMID:
29763961
3.

Antiphospholipid antibodies induce thrombosis by PP2A activation via apoER2-Dab2-SHC1 complex formation in endothelium.

Sacharidou A, Chambliss KL, Ulrich V, Salmon JE, Shen YM, Herz J, Hui DY, Terada LS, Shaul PW, Mineo C.

Blood. 2018 May 10;131(19):2097-2110. doi: 10.1182/blood-2017-11-814681. Epub 2018 Mar 2.

4.

Identifying Additional Risk Factors for Thrombosis and Pregnancy Morbidities Among Antiphospholipid Antibodies Carriers.

Zuo Y, Fan J, Sarode R, Zhang S, Makris UE, Karp DR, Shen YM.

Clin Appl Thromb Hemost. 2018 Sep;24(6):980-985. doi: 10.1177/1076029618755946. Epub 2018 Feb 22.

5.

Evaluating Thrombocytopenia During Heparin Therapy.

Shen YM, Wolfe H, Barman S.

JAMA. 2018 Feb 6;319(5):497-498. doi: 10.1001/jama.2017.21898. No abstract available.

PMID:
29411014
6.

A case of autoimmune severe acquired von Willebrand syndrome (type 3-like).

Gavva C, Patel P, Shen YM, Frenkel E, Sarode R.

Transfus Apher Sci. 2017 Jun;56(3):431-433. doi: 10.1016/j.transci.2017.04.006. Epub 2017 Apr 27.

PMID:
28512017
7.

Coagulation Testing in a Bleeding Patient.

Choi SH, Rambally S, Shen YM.

JAMA. 2017 Apr 11;317(14):1479-1480. doi: 10.1001/jama.2017.2420. No abstract available.

PMID:
28399246
8.

Mixing Study for Evaluation of Abnormal Coagulation Testing.

Choi SH, Rambally S, Shen YM.

JAMA. 2016 Nov 22;316(20):2146-2147. doi: 10.1001/jama.2016.15749. No abstract available.

PMID:
27893111
9.
10.

Can an anti-Xa assay for low-molecular-weight heparin be used to assess the presence of rivaroxaban?

Yates SG, Smith S, Tharpe W, Shen YM, Sarode R.

Transfus Apher Sci. 2016 Oct;55(2):212-215. doi: 10.1016/j.transci.2016.06.005. Epub 2016 Jun 27.

PMID:
27377884
11.

Identification of a Monoclonal Antibody That Attenuates Antiphospholipid Syndrome-Related Pregnancy Complications and Thrombosis.

Mineo C, Lanier L, Jung E, Sengupta S, Ulrich V, Sacharidou A, Tarango C, Osunbunmi O, Shen YM, Salmon JE, Brekken RA, Huang X, Thorpe PE, Shaul PW.

PLoS One. 2016 Jul 27;11(7):e0158757. doi: 10.1371/journal.pone.0158757. eCollection 2016.

12.

Analysis of Thrombophilia Test Ordering Practices at an Academic Center: A Proposal for Appropriate Testing to Reduce Harm and Cost.

Shen YM, Tsai J, Taiwo E, Gavva C, Yates SG, Patel V, Frenkel E, Sarode R.

PLoS One. 2016 May 13;11(5):e0155326. doi: 10.1371/journal.pone.0155326. eCollection 2016.

13.

Characteristics and Outcomes of Renal Transplant Recipients with Hemolytic Uremic Syndrome in the United States.

Tanriover B, Lakhia R, Shen YM, Sandikci B, Saxena R, MacConmara M, Soyombo AA, Rajora N, Hardy MA.

Transplant Direct. 2015 Nov;1(10). pii: e41. Epub 2015 Nov 18.

14.

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.

Nathwani AC, Reiss UM, Tuddenham EG, Rosales C, Chowdary P, McIntosh J, Della Peruta M, Lheriteau E, Patel N, Raj D, Riddell A, Pie J, Rangarajan S, Bevan D, Recht M, Shen YM, Halka KG, Basner-Tschakarjan E, Mingozzi F, High KA, Allay J, Kay MA, Ng CY, Zhou J, Cancio M, Morton CL, Gray JT, Srivastava D, Nienhuis AW, Davidoff AM.

N Engl J Med. 2014 Nov 20;371(21):1994-2004. doi: 10.1056/NEJMoa1407309.

15.

Antiphospholipid antibodies attenuate endothelial repair and promote neointima formation in mice.

Ulrich V, Konaniah ES, Lee WR, Khadka S, Shen YM, Herz J, Salmon JE, Hui DY, Shaul PW, Mineo C.

J Am Heart Assoc. 2014 Oct 14;3(5):e001369. doi: 10.1161/JAHA.114.001369.

16.

Bortezomib for chronic relapsing thrombotic thrombocytopenic purpura: a case report.

Yates S, Matevosyan K, Rutherford C, Shen YM, Sarode R.

Transfusion. 2014 Aug;54(8):2064-7. doi: 10.1111/trf.12614. Epub 2014 Mar 24.

PMID:
24655327
17.

Fibrinogen Dusart presenting as recurrent thromboses in the hepatic portal system.

Shen YM, Trang V, Sarode R, Brennan S.

Blood Coagul Fibrinolysis. 2014 Jun;25(4):392-4. doi: 10.1097/MBC.0000000000000045.

PMID:
24384913
18.

Role of ADAMTS13 in the management of thrombotic microangiopathies including thrombotic thrombocytopenic purpura (TTP).

Shah N, Rutherford C, Matevosyan K, Shen YM, Sarode R.

Br J Haematol. 2013 Nov;163(4):514-9. doi: 10.1111/bjh.12569. Epub 2013 Sep 20.

PMID:
24111495
19.

Incidence of isolated heparin-induced thrombocytopenia and risk of thrombosis by IgG-specific anti-PF4/heparin ELISA.

Radaideh SM, Frenkel EP, Dowell JE, Sarode R, Shen YM.

Clin Appl Thromb Hemost. 2012 Mar-Apr;18(2):215-7. doi: 10.1177/1076029611423389. Epub 2011 Nov 8.

PMID:
22067544
20.

Rare deletion from the fibrinogen Bβ gene in a patient with a provoked venous thrombotic event.

Shen YM, Sarode R, Bhogaraju A, Brennan S.

Blood Coagul Fibrinolysis. 2011 Oct;22(7):613-5. doi: 10.1097/MBC.0b013e328349f1b8.

PMID:
21959590

Supplemental Content

Loading ...
Support Center